WallStreetZenWallStreetZen

NASDAQ: MASS
908 Devices Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MASS

Based on 2 analysts offering 12 month price targets for 908 Devices Inc

Min Forecast
$12.00+12.36%
Avg Forecast
$12.50+17.04%
Max Forecast
$13.00+21.72%

Should I buy or sell MASS stock?

Based on 2 analysts offering ratings for 908 Devices Inc.

Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MASS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MASS as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their MASS stock forecasts and price targets.

MASS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-12Find Out Why
lockedlocked$00.00+00.00%2026-08-12

1 of 1

Forecast return on equity

Is MASS forecast to generate an efficient return?

Company
N/A
Industry
23.24%
Market
166.97%

Forecast return on assets

Is MASS forecast to generate an efficient return on assets?

Company
N/A
Industry
13.76%

MASS earnings per share forecast

What is MASS's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$0.62
Avg 2 year Forecast
-$0.40
Avg 3 year Forecast
-$0.24

MASS revenue forecast

What is MASS's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$70.0M+14.99%
Avg 2 year Forecast
$83.6M+37.47%
Avg 3 year Forecast
$98.1M+61.25%
MASS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MASS revenue growth forecast

How is MASS forecast to perform vs Medical Devices companies and vs the US market?

Company
17.2%
Industry
7.6%
Market
13.27%
MASS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MASS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MASS vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
MASS$10.68$12.50+17.04%Strong Buy
SGHT$8.26$8.25-0.12%Strong Buy
SI$22.06$26.33+19.37%Strong Buy
PACB$1.35$1.50+11.11%Strong Sell
CLPT$15.39$25.00+62.44%Strong Buy
View Top Medical Device Stocks

908 Devices Stock Forecast FAQ

Is 908 Devices Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: MASS) stock is to Strong Buy MASS stock.

Out of 2 analysts, 2 (100%) are recommending MASS as a Strong Buy, 0 (0%) are recommending MASS as a Buy, 0 (0%) are recommending MASS as a Hold, 0 (0%) are recommending MASS as a Sell, and 0 (0%) are recommending MASS as a Strong Sell.

If you're new to stock investing, here's how to buy 908 Devices stock.

What is MASS's earnings growth forecast for 2026-2028?

(NASDAQ: MASS) 908 Devices's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 22.87%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.28%.

908 Devices's earnings in 2026 is -$34,657,000.On average, 6 Wall Street analysts forecast MASS's earnings for 2026 to be -$25,436,762, with the lowest MASS earnings forecast at -$27,544,781, and the highest MASS earnings forecast at -$22,134,199. On average, 6 Wall Street analysts forecast MASS's earnings for 2027 to be -$16,442,548, with the lowest MASS earnings forecast at -$19,443,375, and the highest MASS earnings forecast at -$13,020,117.

In 2028, MASS is forecast to generate -$10,118,491 in earnings, with the lowest earnings forecast at -$9,721,687 and the highest earnings forecast at -$10,416,094.

What is MASS's revenue growth forecast for 2026-2028?

(NASDAQ: MASS) 908 Devices's forecast annual revenue growth rate of 17.2% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.6%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.27%.

908 Devices's revenue in 2026 is $60,840,000.On average, 7 Wall Street analysts forecast MASS's revenue for 2026 to be $2,891,582,001, with the lowest MASS revenue forecast at $2,746,376,695, and the highest MASS revenue forecast at $3,007,647,044. On average, 7 Wall Street analysts forecast MASS's revenue for 2027 to be $3,456,985,751, with the lowest MASS revenue forecast at $3,256,765,284, and the highest MASS revenue forecast at $3,649,022,145.

In 2028, MASS is forecast to generate $4,055,125,796 in revenue, with the lowest revenue forecast at $3,726,646,843 and the highest revenue forecast at $4,355,745,833.

What is MASS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MASS) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 13.76%.

What is MASS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year MASS price target, the average MASS price target is $12.50, with the highest MASS stock price forecast at $13.00 and the lowest MASS stock price forecast at $12.00.

On average, Wall Street analysts predict that 908 Devices's share price could reach $12.50 by Aug 12, 2027. The average 908 Devices stock price prediction forecasts a potential upside of 17.04% from the current MASS share price of $10.68.

What is MASS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MASS) 908 Devices's current Earnings Per Share (EPS) is -$0.94. On average, analysts forecast that MASS's EPS will be -$0.62 for 2026, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.54. On average, analysts forecast that MASS's EPS will be -$0.40 for 2027, with the lowest EPS forecast at -$0.47, and the highest EPS forecast at -$0.32. In 2028, MASS's EPS is forecast to hit -$0.24 (min: -$0.24, max: -$0.25).

What is MASS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MASS) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.